Paper Details

  1. Home
  2. Paper Details

Efficacy and Safety Analysis of Piperacillin Tazobactam in Combination With High Frequency Chest Wall Oscillation in Patients With COPD Coupled With Pneumonia.

Author: FengQiong, LiFajiu, LiLi, MengQinghua

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory lung disease. Acute exacerbation of COPD (AE-COPD) can be complicated by pneumonia, leading to recurrent attacks. Conventional treatments for AE-COPD with pneumonia are often ineffective.
Paper Details　
Original Abstract of the Article :
Chronic obstructive pulmonary disease (COPD) is a common, chronic inflammatory disease of the airway, and acute exacerbation of COPD (AE-COPD) refers to the manifestations of inflammation in the lungs that appear within a short period of time. Some patients contract pneumonia, and they can be prone ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/35986739

データ提供：米国国立医学図書館（NLM）

Piperacillin Tazobactam and High Frequency Chest Wall Oscillation for COPD

This study investigates the efficacy of a combination therapy using piperacillin tazobactam, an antibiotic, and high-frequency chest wall oscillation (HFCWO), a respiratory therapy, for patients with COPD coupled with pneumonia. The researchers explored this approach to improve treatment outcomes for this challenging condition.

A Potential Solution for COPD

This study suggests that the combination therapy may offer a promising solution for patients with COPD and pneumonia. It may help improve lung function and reduce the severity of infections.

Improving Respiratory Care

This research highlights the importance of exploring new and innovative approaches to respiratory care. It is a reminder that we must continue to seek out better ways to treat complex respiratory conditions.

Dr.Camel's Conclusion

This study explores the potential of a combination therapy for COPD, demonstrating the ongoing search for better treatment options for this common and challenging condition. It is a reminder that we must continue to innovate and seek out effective solutions to improve patient care.

Date :
  1. Date Completed 2022-12-26
  2. Date Revised 2022-12-26
Further Info :

Pubmed ID

35986739

DOI: Digital Object Identifier

AT7561

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.